Skip to main content
Top
Published in: Diseases of the Colon & Rectum 10/2007

01-10-2007 | Original Contributions

Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register

Authors: Carlos A. Vaccaro, M.D., Fernando Bonadeo, M.D., Analía V. Roverano, M.D., Paivi Peltomaki, M.D., Shashi Bala, Ph.D., Elise Renkonen, Ph.D., Maria A. Redal, Ph.D., Esteban Mocetti, M.D., Eduardo Mullen, M.D., Guillermo Ojea-Quintana, M.D., Mario L. Benati, M.D., Hernan Garcia Rivello, M.D., Mary B. Clark, M.S.W., Jane F. Lynch, B.S.N., Henry T. Lynch, M.D.

Published in: Diseases of the Colon & Rectum | Issue 10/2007

Login to get access

Abstract

Purpose

The first Argentine experience with epidemiologic, molecular, and genetic counseling data is reported.

Methods

We analyzed 43 families fulfilling Amsterdam criteria identified from a prospective database with data from 779 relatives.

Results

Eleven families (25.6 percent) presented as Lynch I, 29 (67.4 percent) as Lynch II, and 3 (7 percent) as Muir-Torre syndrome. Among the 306 affected members, 197 cases of colorectal cancer were identified (mean age at diagnosis, 52.1 (range, 21–90) years). The most frequent extracolonic tumors were gastric adenocarcinoma in males and endometrium adenocarcinoma in females. A high incidence of breast cancer was observed (16 cases among 155 females, crude rate: 11,594.20/100,000). Twenty-seven patients (8.8 percent) developed more than one tumor. These patients were younger than those with only one tumor (45 vs. 51 years; P = 0.001). In 5 of 11 patients who underwent molecular sequencing, a pathologic mutation was found. A novel C deletion at 1910 nucleotide, codon 637, exon 12 of MSH2 gene was identified in a family with a strong aggregation of breast cancer with lack of MSH2 immunohistochemical staining. For 78.2 percent of counseled individuals, this session represented the first time they received information, and 73.9 percent stated that their physicians were unaware of their family background.

Conclusions

Argentine families presented a high incidence of stomach cancer. The elevated incidence of breast cancer and its association with a novel hMSH2 mutation bring to consideration the inclusion of this malignancy as part of the syndrome. A lack of awareness by both physicians and persons at risk was observed.
Literature
1.
go back to reference Voskuil DW, Vasen H, Kampman E, van’t Veer P. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. Int J Cancer 1997;72:205–9.PubMedCrossRef Voskuil DW, Vasen H, Kampman E, van’t Veer P. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. Int J Cancer 1997;72:205–9.PubMedCrossRef
2.
go back to reference Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition: Update of ICG-HNPCC-INSiGHT mutation database. Dis Markers 2004;20:269–76.PubMed Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition: Update of ICG-HNPCC-INSiGHT mutation database. Dis Markers 2004;20:269–76.PubMed
3.
go back to reference Wijnen J, de Leeuw W, Vasen H, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999;23:142–4.PubMedCrossRef Wijnen J, de Leeuw W, Vasen H, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999;23:142–4.PubMedCrossRef
5.
go back to reference Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum and larynx associated with kerato-acanthoma of the face. Br J Surg 1967;54:191–5.PubMedCrossRef Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum and larynx associated with kerato-acanthoma of the face. Br J Surg 1967;54:191–5.PubMedCrossRef
7.
go back to reference Zhang YZ, Sheng JQ, Li SR, Zhang H. Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol 2005;11:1481–8.PubMed Zhang YZ, Sheng JQ, Li SR, Zhang H. Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol 2005;11:1481–8.PubMed
8.
go back to reference Rossi BM, Lopes A, Oliveira Ferreira F, et al. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555–61.PubMed Rossi BM, Lopes A, Oliveira Ferreira F, et al. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555–61.PubMed
9.
go back to reference Rossi BM, Corvello CM, Epelman M, et al. Hereditary colorectal tumors: routine care and the multidisciplinary therapeutic approach. S Am J Cancer 1997;1:191–7. Rossi BM, Corvello CM, Epelman M, et al. Hereditary colorectal tumors: routine care and the multidisciplinary therapeutic approach. S Am J Cancer 1997;1:191–7.
10.
go back to reference Ferreira Oliveira F, Ferreira Napoli CC, Rossi BM, et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families. Fam Cancer 2004;3:41–7.CrossRef Ferreira Oliveira F, Ferreira Napoli CC, Rossi BM, et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families. Fam Cancer 2004;3:41–7.CrossRef
11.
go back to reference Sarroca C, Peltomaki P, Alfano N, et al. Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch II) in Uruguay. Cancer Genet Cytogenet 2003;142:13–20.PubMedCrossRef Sarroca C, Peltomaki P, Alfano N, et al. Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch II) in Uruguay. Cancer Genet Cytogenet 2003;142:13–20.PubMedCrossRef
12.
go back to reference Sarroca C, Valle AD, Fresco R, Renkonen R, Peltomaki P, Lynch H. Frequency of hereditary non-polyposis colorectal cancer in Uruguayan patients with colorectal cancer. Clin Genet 2005;68:80–7.PubMedCrossRef Sarroca C, Valle AD, Fresco R, Renkonen R, Peltomaki P, Lynch H. Frequency of hereditary non-polyposis colorectal cancer in Uruguayan patients with colorectal cancer. Clin Genet 2005;68:80–7.PubMedCrossRef
13.
go back to reference Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.PubMedCrossRef Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.PubMedCrossRef
14.
go back to reference Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453–6.PubMedCrossRef Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453–6.PubMedCrossRef
15.
go back to reference Renkonen E, Zhang Y, Lohi H, et al. Altered expression of MLH1, MSH2 and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003;21:3629–37.PubMedCrossRef Renkonen E, Zhang Y, Lohi H, et al. Altered expression of MLH1, MSH2 and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003;21:3629–37.PubMedCrossRef
16.
go back to reference Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of inmunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 2001;1:87–92.PubMedCrossRef Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of inmunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 2001;1:87–92.PubMedCrossRef
17.
go back to reference Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248–57.PubMed Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248–57.PubMed
18.
go back to reference Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States: the state of the union. Dis Colon Rectum 2004;47:674–8.PubMedCrossRef Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States: the state of the union. Dis Colon Rectum 2004;47:674–8.PubMedCrossRef
19.
go back to reference Rodriguez-Bigas MA, Lee PH, O’Malley L, et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:649–53.PubMedCrossRef Rodriguez-Bigas MA, Lee PH, O’Malley L, et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:649–53.PubMedCrossRef
20.
go back to reference Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 1987;206:289–95.PubMedCrossRef Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 1987;206:289–95.PubMedCrossRef
21.
go back to reference Goecke T, Schulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006;24:4285–92.PubMedCrossRef Goecke T, Schulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006;24:4285–92.PubMedCrossRef
22.
go back to reference Mangold E, Pagesntecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of MSH2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004;41:567–72.PubMedCrossRef Mangold E, Pagesntecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of MSH2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004;41:567–72.PubMedCrossRef
23.
go back to reference Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979–85.PubMedCrossRef Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979–85.PubMedCrossRef
Metadata
Title
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register
Authors
Carlos A. Vaccaro, M.D.
Fernando Bonadeo, M.D.
Analía V. Roverano, M.D.
Paivi Peltomaki, M.D.
Shashi Bala, Ph.D.
Elise Renkonen, Ph.D.
Maria A. Redal, Ph.D.
Esteban Mocetti, M.D.
Eduardo Mullen, M.D.
Guillermo Ojea-Quintana, M.D.
Mario L. Benati, M.D.
Hernan Garcia Rivello, M.D.
Mary B. Clark, M.S.W.
Jane F. Lynch, B.S.N.
Henry T. Lynch, M.D.
Publication date
01-10-2007
Publisher
Springer-Verlag
Published in
Diseases of the Colon & Rectum / Issue 10/2007
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI
https://doi.org/10.1007/s10350-007-9037-y

Other articles of this Issue 10/2007

Diseases of the Colon & Rectum 10/2007 Go to the issue